Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MariMed Inc. (MRMD : OTC)
 
 • Company Description   
MariMed Inc. is a multi-state cannabis operator. The Company develops, owns and manages seed to sale state-licensed cannabis facilities, which are models in horticultural principles, cannabis cultivation, cannabis-infused products and dispensary operations. Its products and brands, includes Betty's Eddies(R), Nature's Heritage(TM), Bourne Baking Co. and K-Fusion(R). MariMed Inc. is based in NORWOOD, Mass.

Number of Employees: 923

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.06 Daily Weekly Monthly
20 Day Moving Average: 569,829 shares
Shares Outstanding: 402.95 (millions)
Market Capitalization: $22.52 (millions)
Beta: 1.39
52 Week High: $0.16
52 Week Low: $0.05
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.46% -24.96%
12 Week -17.55% -22.24%
Year To Date -40.53% -47.52%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10 Oceana Way
-
Norwood,MA 02062
USA
ph: 781-277-0007
fax: -
ir@marimedinc.com http://www.marimedinc.com
 
 • General Corporate Information   
Officers
Jon R. Levine - President and Chief Executive Officer
Edward Gildea - Chairman of the Board and Director
Mario Pinho - Chief Financial Officer
David Allen - Director
Eva Selhub - Director

Peer Information
MariMed Inc. (BJCT)
MariMed Inc. (CADMQ)
MariMed Inc. (APNO)
MariMed Inc. (UPDC)
MariMed Inc. (IMTIQ)
MariMed Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 56782V107
SIC: 2833
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 06/01/26
Next Expected EPS Date: 11/04/26
Share - Related Items
Shares Outstanding: 402.95
Most Recent Split Date: (:1)
Beta: 1.39
Market Capitalization: $22.52 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/04/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.52
Price/Cash Flow: 2.41
Price / Sales: 0.14
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: 5.84%
vs. Previous Quarter: 6.19%
ROE
09/30/26 - -
06/30/26 - -10.71
03/31/26 - -5.00
ROA
09/30/26 - -
06/30/26 - -2.58
03/31/26 - -1.29
Current Ratio
09/30/26 - -
06/30/26 - 0.92
03/31/26 - 0.95
Quick Ratio
09/30/26 - -
06/30/26 - 0.34
03/31/26 - 0.34
Operating Margin
09/30/26 - -
06/30/26 - -3.17
03/31/26 - -1.62
Net Margin
09/30/26 - -
06/30/26 - -9.13
03/31/26 - -7.82
Pre-Tax Margin
09/30/26 - -
06/30/26 - -6.21
03/31/26 - -5.78
Book Value
09/30/26 - -
06/30/26 - 0.11
03/31/26 - 0.12
Inventory Turnover
09/30/26 - -
06/30/26 - 2.76
03/31/26 - 2.67
Debt-to-Equity
09/30/26 - -
06/30/26 - 1.78
03/31/26 - 1.67
Debt-to-Capital
09/30/26 - -
06/30/26 - 63.98
03/31/26 - 62.52
 

Powered by Zacks Investment Research ©